GDM meds differ in effects on birth weight: review
A meta-analysis including Australian studies compares insulin, metformin and glibenclamide
Three therapies used for glycaemic control in women with gestational diabetes (GDM) have differing effects on the baby’s birth weight, a meta-analysis shows.
Researchers from the University of Cambridge, UK, analysed 33 trials including almost 5000 women with gestational diabetes randomised to metformin, insulin or glibenclamide.
